TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants retained after the 12-week intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum tolerated dose (MTD) of AVB-S6-500
Endpoint domain: Adverse events/effects
Primary endpoint: Dose limiting toxicities (DLTs) of AVB-S6-500
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of the combination at the MTD
Endpoint domain: Adverse events/effects
Primary endpoint: Qualified overall survival (qOS)
Endpoint domain: Mortality/survival
Primary endpoint: Pharmacokinetic profile of liraglutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Manual skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adult Functioning Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rehabilitation Success
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of CIED-related infection
Endpoint domain: Adverse events/effects
Primary endpoint: day-time continence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: night-time continence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative sexual function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of studies with difference in wall thickness greater than 0.3cm for LVIDd
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of studies with difference in wall thickness greater than 0.2cm for IVSd
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of studies with difference in wall thickness greater than 0.2cm for LVPWd
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean absolute error (MAE) of LVIDd between preliminary to overread
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean absolute error (MAE) of IVSd between preliminary to overread
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of chemotherapy-induced alopecia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient distress during treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility Failure Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Native Reliance Questionnaire (NRQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Assessment of Individual Needs-Quick (GAIN-Q)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Commercial Tobacco Use
Endpoint domain: Adverse events/effects
Primary endpoint: Pediatric Respiratory Assessment Measure (PRAM) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of Oral Lichen Planus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preserved immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome score (KOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feasibility - participants willingness to be included
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence - participants adherence to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance to home exercises
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participants impression of change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: International Index of Erectile Function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in frequency of complete spontaneous bowel movements (CSBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in dyspnea VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depression, Anxiety, and Stress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Interincisal Mouth Opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Intra-articular pain (IAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Joint Sound Presence and Characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of trigger finger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular risk reduction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systolic pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of participants showing CR/CRi/CRh without MRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinic systolic brachial BP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Torque TenoVirus replication (in copies/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: IV morphine equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to CPAP therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seroconversion rate of anti-HAV antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidences of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Pregnancy-related lumbopelvic pain (PLPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression, anxiety and stress in general with the Depression Anxiety Stress Scale (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pregnancy-related anxiety with the Revised Pregnancy-related Anxiety Questionnaire (PRAQ-R2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of median nerve abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Subjects Reaching the Efficacy Goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past 30-Day Substance Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child and Youth Resilience Measure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1-Year Graft Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' initial stress and anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quadriceps Isometric Peak Torque Limb Symmetry Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in KOOS Knee-related Quality of Life Subscale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Probability of attaining 90% single-leg hop symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liebowitz Social Anxiety Scale Self Report Version
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Personal Report of Communication Apprehension (PRCA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adoption of Measurement-Based Care (MBC) strategies
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Strengths and Difficulties Questionnaire (SDQ) youth and caregiver report scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Clinician and Youth Working Alliance Inventory--Short Form scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of Treatment-Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Sustained Alleviation of Overall COVID-19 Signs and Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life after gynaecological malignancies diagnosis and treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: scar/wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scar/wound depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scar erythema and pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting ILI episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants presenting RT-PCR confirmed influenza A or B cases
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants presenting RT-PCR confirmed SARS-CoV-2 cases
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Any Occurrence of Amyloid-Related Imaging Abnormality-Edema/Effusion (ARIA-E)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change in pulmonary vascular resistance (PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in cycloplegic refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects without upper respiratory tract infection with nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of change in post-BD FEV1 slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in gene expression of transgelin-2, metallothionein-2 and ezrin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate sedation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation to recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation to wake-up time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midazolam use
Endpoint domain: Adverse events/effects
Primary endpoint: Peri-implant mucosal volumetric change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heel Tenderness Index (HTI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Shoulder and Elbow Surgeons Score (ASES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Connor-Davidson Psychological Resilience Scale (CDPRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression, Anxiety, Stress-21 Scale (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functionality of Upper Limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homework compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Credibility as measured by 3 questions designed for the study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Client Satisfaction Questionnaire-4 (CSQ-4)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reliable change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Need for repeated doses of treatments to reach target blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to reach target blood pressure after treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptomatic effectiveness of glutamine supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: BBB permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metabolomics profile in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in BVCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in total tics on the YGTSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of the integrative cluster (IntClust) and intrinsic (PAM50) subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Molecular signatures of primary tumor specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Healthcare utilization (work impairment percentages)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthcare utilization-associated costs (total amount in AUD)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detection of CSDs (Cerebrospinal fluid leaks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tumor tissue samples collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Urinary ATP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve from 0 to the Last Quantifiable Time Point (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic marginal bone change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage Change in fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complete wound healing evidenced by substantially complete epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of device-related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in postprandial triglyceridemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ca19-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ERG signal quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular irritation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in inflammatory markers in the serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate specific antigen (PSA) persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical recurrence free survival (BCRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Postoperative Delayed Gastric Emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PTSD Check List for DSM-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep efficiency from 7-day sleep diary
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: AUROC curve for cTnI concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of rifampicin resistant S. aureus
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day repeat admission rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for repeat head imaging
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cold detection threshold (CDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hot detection threshold (HDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Shunt primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients recruited from screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Repeatability of CFR and IMR value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence and severity of Local Skin Reactions (erythema, edema, bruising)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Presence and severity of Local Skin Reactions (pain and stinging/burning)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of cardiac arrhythmia / atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of common symptoms of arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with ANS-neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ECMO cannula-related infection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Corpus Callosum Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Masticatory Efficiency Using Soft Food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Masticatory Efficiency Using Hard Food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission after diet intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal Stress Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval to first rescue analgesia dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mMASI scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of Global Tolerance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rate of major infection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Voluntary Activation Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Tau protein isoforms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Adaptation Magnitude Assessed as Peak Step Length Symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 10-Meter Overground Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Montreal Cognitive Assessment (MoCA) Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in PASI 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in sPGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients who achieve CD4+IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in Ankylosing Spondylitis Disease Activity Score (ASDAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in wound remaining closed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Social integration during inpatient treatment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in neural responses to interpersonal touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in mood in response to a social interaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Voice Range Profile (VRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in motor function of the upper limbs (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in motor function of the upper limbs (ARAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Prevalence of persisting SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Resistance-Associated Pre-Treatment Substitutions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance-Associated Treatment-Emergent Substitutions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of RBCs used over admission
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total number of platelets used over admission
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total number of plasma used over admission
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical efficacy of Vvax001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVIM parameters (ADC, D, D*, f)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of ICU
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants who successfully receive glofitamab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montreal cognitive assessment scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time up and Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes